Estrategias paliativas en los tumores digestivos
- Cigarral, B. 1
- Fonseca, E. 1
- Vidal Tocino, R. 1
- Barrios, B. 1
- Casado, D. 1
- Claros, J. 1
- Escalera, E. 1
- Olivares, A. 1
- Figuero, L. 1
- Terán, E. 1
- López, A. 1
- Cruz, J.J. 1
- 1 Instituto de Investigación Biomédica de Salamanca (IBSAL), Servicio de Oncología Médica, Complejo Asistencial Universitario de Salamanca (CAUSA), Salamanca, España
ISSN: 0304-5412
Argitalpen urtea: 2021
Saila: 13
Zenbakia: 24
Orrialdeak: 1360-1363
Mota: Artikulua
Beste argitalpen batzuk: Medicine: Programa de Formación Médica Continuada Acreditado
Laburpena
In patients who present with advanced gastrointestinal cancer who may be overcome by an incurable, progressive condition, supportive treatment is fundamental to improving quality of life and promoting the patient's autonomy through an interdisciplinary and multidisciplinary approach. In gastrointestinal tumors, the main complications that may occur are obstructive problems (in the bile duct or bowel area), symptoms of nausea and vomiting, constipation, ascites, or cachexia-anorexia syndrome. Early identification and treatment are key to patients’ well-being.
Erreferentzia bibliografikoak
- Porta J, Gómez X, Tuca A. Manual control de síntomas en pacientes con cáncer avanzado y terminal. 3ª ed. Madrid: Arán; 2013.
- Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D; ESMO Guidelines Committee. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27Suppl5:v28–v37.
- Feliu J, Castelo B, Ghanem I, et al. Manual SEOM de Cuidados Continuos. 2ª ed. Madrid: Gonext Producciones S.L.;2014.
- Dans M, Kutner JS, Baker JN, Bauman JR, Beck AC, Campbell TC et al. Palliative care. Version 1.2020. NCCN Guidelines.